{"transactions":[{"id":833602,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-19T18:41:25.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":21279,"price":6.423,"value":136675.017,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 149,833 RSUs."}],"balance_after":189446,"source":{"system":"sec-edgar","filing":"0001610717-26-000125","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000161071726000125/form4.xml","form_type":"4"}},{"id":919583,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T16:27:02.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2026 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":300000,"derivative":{"exercise_price":6.09,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001610717-26-000042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000161071726000042/form4.xml","form_type":"4"}},{"id":919582,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-04T16:27:02.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on March 15 of each year, with the first 1/3rd vesting on March 15, 2027, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 206,000 RSUs."}],"balance_after":210725,"source":{"system":"sec-edgar","filing":"0001610717-26-000042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000161071726000042/form4.xml","form_type":"4"}},{"id":1030621,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Performance Stock Units (PSUs)","published_at":"2025-09-30T18:39:31.000Z","date":"2025-09-26","kind":"grant","planned":false,"acquired":true,"shares":43750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/3 of the PSUs vest upon the achievement of each of three clinical milestones, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/3 of the PSUs vest upon the achievement of each of three clinical milestones, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/3 of the PSUs vest upon the achievement of each of three clinical milestones, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":43750,"derivative":{"underlying":"Common Stock","underlying_shares":43750},"source":{"system":"sec-edgar","filing":"0001610717-25-000356","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000161071725000356/form4.xml","form_type":"4"}},{"id":1030620,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-30T18:39:31.000Z","date":"2025-09-26","kind":"grant","planned":false,"acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from September 26, 2025 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":87500,"derivative":{"exercise_price":2.9,"expiration_date":"2035-09-25","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001610717-25-000356","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000161071725000356/form4.xml","form_type":"4"}},{"id":1195807,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-20T16:32:56.000Z","date":"2025-03-18","kind":"sale","planned":false,"acquired":false,"shares":4025,"price":0.599,"value":2410.975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 131,000 RSUs."}],"balance_after":135725,"source":{"system":"sec-edgar","filing":"0001610717-25-000084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000161071725000084/form4.xml","form_type":"4"}},{"id":1280407,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-06T17:55:51.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/24th of the shares subject to the option vest on each monthly anniversary measured from the Vesting Commencement Date, such that 100% of the shares subject to the option will be fully vested and exercisable on the second anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":115000,"derivative":{"exercise_price":0.864,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001610717-25-000018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000161071725000018/form4.xml","form_type":"4"}},{"id":1280406,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-06T17:55:51.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":238000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 4, 2025 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":238000,"derivative":{"exercise_price":0.864,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":238000},"source":{"system":"sec-edgar","filing":"0001610717-25-000018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000161071725000018/form4.xml","form_type":"4"}},{"id":1280405,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-06T17:55:51.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":57500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Constitute RSUs for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 50% of the RSUs vest annually on March 15 of each year, with the first 50% vesting on March 15, 2026, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 139,750 RSUs."}],"balance_after":139750,"source":{"system":"sec-edgar","filing":"0001610717-25-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000161071725000018/form4.xml","form_type":"4"}},{"id":1280404,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-06T17:55:51.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on March 15 of each year, with the first 1/3rd vesting on March 15, 2026, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":82250,"source":{"system":"sec-edgar","filing":"0001610717-25-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000161071725000018/form4.xml","form_type":"4"}},{"id":1675391,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Performance Stock Units (PSUs)","published_at":"2024-01-19T20:37:27.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/2 of the PSUs vest upon the achievement of each of two clinical milestones, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/2 of the PSUs vest upon the achievement of each of two clinical milestones, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/2 of the PSUs vest upon the achievement of each of two clinical milestones, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":75000,"derivative":{"underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001610717-24-000031","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000161071724000031/form4.xml","form_type":"4"}},{"id":1675390,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-19T20:37:27.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":122500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 18, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":122500,"derivative":{"exercise_price":1.68,"expiration_date":"2034-01-17","underlying":"Common Stock","underlying_shares":122500},"source":{"system":"sec-edgar","filing":"0001610717-24-000031","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000161071724000031/form4.xml","form_type":"4"}},{"id":1675389,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-19T20:37:27.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on March 15 of each year, with the first 1/3rd vesting on March 15, 2025, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 26,250 RSUs."}],"balance_after":26250,"source":{"system":"sec-edgar","filing":"0001610717-24-000031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000161071724000031/form4.xml","form_type":"4"}},{"id":1825914,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T17:18:02.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the one year anniversary measured from July 19, 2023 (the \"Vesting Commencement Date\"), and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":375000,"derivative":{"exercise_price":1.82,"expiration_date":"2033-07-18","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001610717-23-000208","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000161071723000208/form4.xml","form_type":"4"}},{"id":1917307,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-04-19T16:07:25.000Z","date":"2023-04-18","kind":"sale","planned":true,"acquired":false,"shares":2317,"price":6.58,"value":15245.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 7,500 shares of Common Stock underlying RSUs granted to the Reporting Person on April 15, 2019. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $6.56 to $6.60 per share."}],"balance_after":140676,"source":{"system":"sec-edgar","filing":"0001209191-23-024820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919123024820/doc4.xml","form_type":"4"}},{"id":1917306,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-04-19T16:07:25.000Z","date":"2023-04-18","kind":"sale","planned":true,"acquired":false,"shares":215,"price":6.52,"value":1401.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 7,500 shares of Common Stock underlying RSUs granted to the Reporting Person on April 15, 2019. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $6.46 to $6.53 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2-3."}],"balance_after":142993,"source":{"system":"sec-edgar","filing":"0001209191-23-024820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919123024820/doc4.xml","form_type":"4"}},{"id":2028821,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-07T16:13:35.000Z","date":"2023-02-06","kind":"grant","acquired":true,"shares":425000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2023, such that all of the shares shall be fully vested and exercisable on January 1, 2026, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":425000,"derivative":{"exercise_price":6.77,"expiration_date":"2033-02-05","underlying":"Common Stock","underlying_shares":425000},"source":{"system":"sec-edgar","filing":"0001209191-23-007497","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919123007497/doc4.xml","form_type":"4"}},{"id":2056573,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-11T16:05:56.000Z","date":"2023-01-10","kind":"sale","acquired":false,"shares":7825,"price":5.24,"value":41003.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the Reporting Person on January 8, 2020, 4,503 shares of Common Stock underlying RSUs granted to the Reporting Person on January 20, 2021, and 8,325 shares of Common Stock underlying RSUs granted to the Reporting Person on January 25, 2022. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $5.12 to $5.34 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":143208,"source":{"system":"sec-edgar","filing":"0001209191-23-002974","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919123002974/doc4.xml","form_type":"4"}},{"id":2292992,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-04-21T16:04:58.000Z","date":"2022-04-19","kind":"sale","acquired":false,"shares":4062,"price":35.37,"value":143672.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 7,500 shares of Common Stock underlying RSUs granted to the reporting person on April 15, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $35.10 to $35.50 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2."}],"balance_after":151033,"source":{"system":"sec-edgar","filing":"0001209191-22-025159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919122025159/doc4.xml","form_type":"4"}},{"id":2424124,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-27T16:37:48.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":53058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in 48 equal month installments beginning on February 1, 2022 such that this option will be fully exercisable on January 1, 2026, subject to the Reporting Person's continued service with the Issuer as of each such date."}],"balance_after":53058,"derivative":{"exercise_price":39.87,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":53058},"source":{"system":"sec-edgar","filing":"0000899243-22-003448","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000089924322003448/doc4.xml","form_type":"4"}},{"id":2424123,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-27T16:37:48.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":33302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of restricted stock units that vest with respect to 1/4th of the underlying shares on each of January 8, 2023, January 8, 2024, January 8, 2025 and January 8, 2026, subject to the Reporting Person's continued service with the Issuer as of each such date."}],"balance_after":155095,"source":{"system":"sec-edgar","filing":"0000899243-22-003448","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000089924322003448/doc4.xml","form_type":"4"}},{"id":2436072,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP Clinical Development"}}],"security":"Common Stock","published_at":"2022-01-13T16:05:33.000Z","date":"2022-01-11","kind":"sale","acquired":false,"shares":418,"price":49.1,"value":20523.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020 and 4,503 shares of Common Stock underlying RSUs granted to the reporting person on January 20, 2021. These sales were made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $48.71 to $49.25 per share."}],"balance_after":121793,"source":{"system":"sec-edgar","filing":"0001209191-22-003166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919122003166/doc4.xml","form_type":"4"}},{"id":2436071,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP Clinical Development"}}],"security":"Common Stock","published_at":"2022-01-13T16:05:33.000Z","date":"2022-01-11","kind":"sale","acquired":false,"shares":3547,"price":48.44,"value":171816.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020 and 4,503 shares of Common Stock underlying RSUs granted to the reporting person on January 20, 2021. These sales were made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $47.68 to $48.67 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 3."}],"balance_after":122211,"source":{"system":"sec-edgar","filing":"0001209191-22-003166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919122003166/doc4.xml","form_type":"4"}},{"id":2475761,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP Clinical Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-13T17:53:51.000Z","date":"2021-12-10","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option shall vest as to 25% of the underlying shares on April 15, 2020 and thereafter on a monthly basis for 36 additional months, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date"}],"balance_after":105000,"derivative":{"exercise_price":16.32,"expiration_date":"2029-04-15","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-21-069313","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919121069313/doc4.xml","form_type":"4"}},{"id":2475760,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP Clinical Development"}}],"security":"Common Stock","published_at":"2021-12-13T17:53:51.000Z","date":"2021-12-10","kind":"sale","acquired":false,"shares":5,"price":55.54,"value":277.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."}],"balance_after":125758,"source":{"system":"sec-edgar","filing":"0001209191-21-069313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919121069313/doc4.xml","form_type":"4"}},{"id":2475759,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP Clinical Development"}}],"security":"Common Stock","published_at":"2021-12-13T17:53:51.000Z","date":"2021-12-10","kind":"sale","acquired":false,"shares":600,"price":54.58,"value":32748.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price of the shares sold ranging from $54.33 to $54.98 per share."}],"balance_after":126763,"source":{"system":"sec-edgar","filing":"0001209191-21-069313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919121069313/doc4.xml","form_type":"4"}},{"id":2475758,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP Clinical Development"}}],"security":"Common Stock","published_at":"2021-12-13T17:53:51.000Z","date":"2021-12-10","kind":"sale","acquired":false,"shares":1031,"price":53.66,"value":55323.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of the shares sold ranging from $53.10 to $54.02 per share."}],"balance_after":126363,"source":{"system":"sec-edgar","filing":"0001209191-21-069313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919121069313/doc4.xml","form_type":"4"}},{"id":2475757,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP Clinical Development"}}],"security":"Common Stock","published_at":"2021-12-13T17:53:51.000Z","date":"2021-12-10","kind":"sale","acquired":false,"shares":1822,"price":52.37,"value":95418.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold ranging from $52.09 to $52.87 per share."}],"balance_after":127394,"source":{"system":"sec-edgar","filing":"0001209191-21-069313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919121069313/doc4.xml","form_type":"4"}},{"id":2475756,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP Clinical Development"}}],"security":"Common Stock","published_at":"2021-12-13T17:53:51.000Z","date":"2021-12-10","kind":"sale","acquired":false,"shares":1045,"price":51.08,"value":53378.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $50.96 to $51.22 per share."}],"balance_after":129216,"source":{"system":"sec-edgar","filing":"0001209191-21-069313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919121069313/doc4.xml","form_type":"4"}},{"id":2475755,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP Clinical Development"}}],"security":"Common Stock","published_at":"2021-12-13T17:53:51.000Z","date":"2021-12-10","kind":"sale","acquired":false,"shares":900,"price":50.42,"value":45378.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $49.96 to $50.89 per share."}],"balance_after":130261,"source":{"system":"sec-edgar","filing":"0001209191-21-069313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919121069313/doc4.xml","form_type":"4"}},{"id":2475754,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP Clinical Development"}}],"security":"Common Stock","published_at":"2021-12-13T17:53:51.000Z","date":"2021-12-10","kind":"sale","acquired":false,"shares":2097,"price":49.32,"value":103424.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $48.95 to $49.87 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 7."}],"balance_after":131161,"source":{"system":"sec-edgar","filing":"0001209191-21-069313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919121069313/doc4.xml","form_type":"4"}},{"id":2475753,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP Clinical Development"}}],"security":"Common Stock","published_at":"2021-12-13T17:53:51.000Z","date":"2021-12-10","kind":"exercise","acquired":true,"shares":7500,"price":16.32,"value":122400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."}],"balance_after":133258,"source":{"system":"sec-edgar","filing":"0001209191-21-069313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919121069313/doc4.xml","form_type":"4"}},{"id":2501071,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP Clinical Development"}}],"security":"Common Stock","published_at":"2021-11-22T17:38:09.000Z","date":"2021-11-19","kind":"grant","acquired":true,"shares":60958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were granted pursuant to a performance-based restricted stock unit award. The units will vest in three approximately equal installments conditioned upon the achievement, on or before December 31, 2026, of up to three specified late-stage clinical and regulatory milestones of the issuer, so long as the reporting person continues to serve as an employee of the issuer through each milestone achievement."}],"balance_after":125758,"source":{"system":"sec-edgar","filing":"0001209191-21-066156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919121066156/doc4.xml","form_type":"4"}},{"id":2744103,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP Clinical Development"}}],"security":"Common stock","published_at":"2021-04-20T16:00:53.000Z","date":"2021-04-16","kind":"sale","acquired":false,"shares":1500,"price":84.41,"value":126615.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 7,500 shares of Common Stock underlying RSUs granted to the reporting person on April 15, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.635 to $84.61 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":64800,"source":{"system":"sec-edgar","filing":"0001209191-21-027545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919121027545/doc4.xml","form_type":"4"}},{"id":2744102,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP Clinical Development"}}],"security":"Common stock","published_at":"2021-04-20T16:00:53.000Z","date":"2021-04-16","kind":"sale","acquired":false,"shares":900,"price":82.91,"value":74619.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 7,500 shares of Common Stock underlying RSUs granted to the reporting person on April 15, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.6175 to $83.23 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":66300,"source":{"system":"sec-edgar","filing":"0001209191-21-027545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919121027545/doc4.xml","form_type":"4"}},{"id":2744101,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":57158,"kind":"person","name":"Chu Yu-Waye","position":1,"cik":"0001854586","reported_name":"Chu Yu-Waye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP Clinical Development"}}],"security":"Common stock","published_at":"2021-04-20T16:00:53.000Z","date":"2021-04-16","kind":"sale","acquired":false,"shares":875,"price":81.8,"value":71575.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 7,500 shares of Common Stock underlying RSUs granted to the reporting person on April 15, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.395 to $82.205 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":67200,"source":{"system":"sec-edgar","filing":"0001209191-21-027545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854586/000120919121027545/doc4.xml","form_type":"4"}}]}